Vanda Pharmaceuticals (VNDA)

Add to Watchlists
Create an Alert
13.83 -0.78  -5.34% NASDAQ Apr 24, 4:59PM BATS Real time Currency in USD
View Full Chart
VNDA Price Chart
View All Events

VNDA Events

Date Type Description
Feb 13 Misc Vanda Pharmaceuticals, Inc. Q4 2013 Earnings Conference Call
Feb 13 Earnings Vanda Pharmaceuticals to Announce Fourth Quarter 2013 Financial Results on February 13, 2014. Estimate: -0.18.
Nov 07 Misc Vanda Pharmaceuticals Q3 2013 Conference Call
Nov 07 Earnings Vanda Pharmaceuticals Q3 2013 Earnings Release. Estimate: -0.37.
Jul 31 Misc Second Quarter 2013 Financial Conference Call and Webcast
Jul 31 Earnings Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013. Estimate: -0.18.
Jun 20 Misc AGM Event for Vanda Pharmaceuticals Inc
May 09 Misc Q1 2013 Vanda Pharmaceuticals Inc. Earnings Conference Call
May 09 Earnings Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013. Estimate: -0.18.
View All Performance Charts

VNDA Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Vanda Pharmaceuticals is up 191.2% over the last year vs S&P 500 Total Return up 21.54%, Jazz Pharmaceuticals up 152.6%, and Actelion up 67.22%.

Get Quote for

PDF Report for VNDA

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download VNDA Pro Report PDF

Portfolio Strategies Featuring VNDA

Did Vanda Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

VNDA Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: District of Columbia
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Vanda Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development and commercialization of products for the treatment of central nervous system disorders such as HETLIOZ, Fanapt and VLY-686.

Recent Quotes

Symbol Price Chg Chg % Market Cap
VNDA 13.83 -0.78 -5.34% 461.07M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.